GlassScriptPhysician profile
Erin Z Latif
NPI 1568408342
$933.02
in general payments reported to CMS, 2019-2025
17 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.47 · 2020: $81.54 · 2021: $66.13 · 2022: $252 · 2023: $133 · 2024: $225 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $466.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $466.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $182.78 | 2022-2024 | Ligasure |
| Astellas Pharma US INC | $148.92 | 2023-2025 | Veozah |
| Abbvie INC. | $133.82 | 2019-2022 | |
| Pfizer INC. | $80.27 | 2023-2025 | |
| Baxter Healthcare | $56.26 | 2022 | |
| Sumitomo Pharma America, INC. | $52.92 | 2023-2025 | Myfembree |
| Boston Scientific Corporation | $38.59 | 2019 | |
| Exeltis, USA INC. | $37.46 | 2023-2024 | Slynd |
| Minerva Surgical, INC | $35.62 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.36 | 2020 | |
| Myovant Sciences INC. | $28.06 | 2022 | |
| Evofem Biosciences, INC. | $25.91 | 2021 | |
| Daiichi Sankyo INC. | $22.24 | 2020-2021 | |
| Aspira Women'S Health INC | $15.59 | 2024 | Ova1 |
| Meditrina | $14.65 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $13.28 | 2023 | Fornisee |
| Conmed Corporation | $12.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Latif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.